CLINICAL_TRIALS
trial_result
· 2026-04-06
Clinical Trial Update: Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis
Summary
Astellas is conducting a Japan post-marketing surveillance study to assess the safety and effectiveness of peficitinib in patients with rheumatoid arthritis, an…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Rheumatoid Arthritis (RA) | Status: RECRUITING